M2M modification actually does not benefit Blackrock in the sense that institutions will not sell the toxic assets for pennies on the dollar anymore. PIMCO, BX, etc. are now forced to buy at higher prices if they want any part of the action. Not as profitable or beneficial in the risk/reward arena as it was originally planned to be. I got out at $8.10 the other day.